Overview

Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI 2 Trial

Status:
RECRUITING
Trial end date:
2030-04-01
Target enrollment:
Participant gender:
Summary
This randomized, multicenter, prospective trial will enroll 6,294 participants in approximately 80 centers. STEMI patients with onset time within 12 hours and scheduled for primary PCI will be randomly assigned to two groups in a 1:1 ratio. Patients meeting the criteria were randomly assigned. It is recommended that loading doses of dual antiplatelet therapy be administered immediately after electrocardiogram diagnosis. The experimental group was required to be given an intravenous injection of 100 U/kg of UFH within 10 minutes after randomization, and this should be completed at least before delivery to the catheter lab. The control group was recommended to be given 100 U/kg of UFH through the arterial sheath, but the actual intraoperative dosage was determined by the interventional cardiologist. No patient is allowed to use low-molecular-weight heparin, bivalirudin, glycoprotein IIb/IIIa inhibitors or other antithrombotic drugs before coronary angiography. The planned enrollment period for this study is 24 months. The scheduled follow-up visits will occur at 30 days (7 days), 3 months (14 days), and if conditions permit, at 6 months (30 days) and 1 year (30 days) after randomization. The purpose of this study is to evaluate the composite endpoint of all-cause death, recurrent myocardial infarction, urgent coronary revascularization, stent thrombosis, or stroke within 30 days after randomization.
Phase:
NA
Details
Lead Sponsor:
Chen Jing
Collaborators:
Anlu Pu'ai Hospital
Caidian District People's Hospital
Changjiang Shipping General Hospital
Chibi People's Hospital
China Resources Wugang General Hospital
Ezhou Central Hospital
Hanyang University
Hubei University of Medicine
Jiangling People's Hospital
Jiangxia First People's Hospital
Jingzhou Central Hospital
Laohekou First Hospital
People's Hospital of Jingshan
Renmin Hospital of Wuhan University
Second Xiangya Hospital of Central South University
Shiyan People's Hospital
Sinopharm Dongfeng General Hospital
Songzi People's Hospital
The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture
The Central Hospital of Huanggang
The Fifth Hospital of Wuhan
The First People's Hospital of Tianmen
The Second Affiliated Hospital of Harbin Medical University
The Third People's Hospital of Hubei Province
Tongcheng People's Hospital of Anhui province
Wuhan Central Hospital
Wuhan Hospital of Traditional Chinese Medicine
Wuhan No.1 Hospital
Wuhan No.3 Hospital
Wuhan No.6 Hospital
Wuhan Puren Hospital
Wuxue First People's Hospital
Xiangyang Central Hospital
Xiangyang Hospital of Traditional Chinese Medicine
Xianning Central Hospital
Xianning First People's Hospital
Xiantao First People's Hospital
Xishui County People's Hospital
Yichang Central People's Hospital
Treatments:
Heparin